BioSpace News Archive

CSL Limited announces a reported net profit after tax of $1.90 billion for the 6 months ended 31 December 2023, up 20% on a constant currency basis.

LeRoy Jones, MD, Board-Certified Urologist and Signati™ Medical, Inc. Board Member, starts a new chapter in his career at Urology Austin.

DEXIS™ announces a new advancement in implant dentistry workflows with the DEXIS digital ecosystem: an interconnected, AI-powered platform for digital implants - combining cutting-edge CBCT, intraoral scanning, diagnostics, and treatment planning.

Tyber Medical LLC, a leading orthopedic device manufacturer providing private label orthopedic implants for the trauma, extremity, and spine markets, has received a U.S. Food and Drug Administration 510 approval for its Proximal Tibia Plating System.

RapidAI, the global leader in developing Artificial Intelligence (AI) and clinical workflow solutions to combat life-threatening neurovascular, cardiac, and vascular diseases, today announced the publication of the TIMELESS trial in the New England Journal of Medicine (NEJM).

Key regulatory milestone advances company’s mission to perfect cancer diagnosis

G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that the independent Data Monitoring Committee (DMC) recommended continuation of the pivotal Phase 3 trial (PRESERVE 2), evaluating trilaciclib in combination with gemcitabine and carboplatin for the first line treatment of metastatic triple negative breast cancer (mTNBC), to the final analysis.

TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX) today announced that it will release financial results for the fourth quarter and full year 2023 after market close on Monday, February 26, 2024.

Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Citi’s 2024 Global Industrial Tech and Mobility Conference in Miami, FL.

ResMed launched its AirCurve 11 series devices, the company’s newest bilevel devices that use two levels of support, inspiratory positive airway pressure and expiratory positive airway pressure, combined with digital technology to make it easier for healthcare providers to treat sleep apnea and to help patients start and stay on therapy.